US Stock MarketDetailed Quotes

ENTO Entero Therapeutics

Watchlist
  • 0.584
  • -0.043-6.83%
Close Dec 13 16:00 ET
  • 0.573
  • -0.011-1.88%
Post 20:01 ET
2.78MMarket Cap0.04P/E (TTM)

Entero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.51%-1.85M
-24.95%-3.45M
-31.68%-3.75M
44.60%-12.38M
38.50%-3.44M
21.69%-3.33M
39.77%-2.76M
64.03%-2.85M
30.80%-22.34M
4.61%-5.59M
Net income from continuing operations
24.84%-2.58M
-110.25%-8.81M
236.77%5.57M
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
Operating gains losses
----
----
----
----
----
----
----
----
20.47%1.71M
----
Depreciation and amortization
-81.74%1.34K
382.54%35.32K
67.98%12.29K
0.01%29.27K
0.01%7.32K
0.00%7.32K
0.01%7.32K
0.01%7.32K
-94.60%29.27K
-94.67%7.32K
Deferred tax
--0
--4.26M
---14.86M
----
----
--0
--0
--0
----
----
Other non cash items
-81.18%17.33K
4,876.12%786.53K
30,879.68%4.81M
-43.40%157.02K
-65.28%33.59K
514.83%92.1K
-32.75%15.81K
-89.08%15.53K
-91.99%277.43K
-96.40%96.76K
Change In working capital
304.07%530.17K
-86.70%147.86K
-46.54%451.15K
120.86%2.19M
114.10%494.53K
97.03%-259.8K
166.72%1.11M
-37.35%843.91K
-161.41%-10.5M
-151.86%-3.51M
-Change in receivables
--0
--0
--0
200.00%93.01K
--0
--0
147.20%20K
360.25%73.01K
-116.87%-93.01K
--98.97K
-Change in prepaid assets
-64.82%152.48K
4.95%351.18K
-37.75%318.34K
575.68%719.26K
27.78%-560.19K
19,337.85%433.46K
26.96%334.6K
42.55%511.39K
-337.02%-151.21K
12.29%-775.73K
-Change in payables and accrued expense
161.69%405.46K
-121.63%-163.4K
-53.73%127.36K
114.31%1.45M
138.31%1.08M
92.38%-657.23K
235.58%755.57K
-74.19%275.27K
-161.81%-10.15M
-484.13%-2.82M
-Change in other current liabilities
22.92%-27.77K
-2,675.03%-39.91K
134.53%5.44K
33.64%-74.05K
-66.53%-23.8K
-103.97%-36.04K
105.25%1.55K
68.55%-15.77K
-258.74%-111.6K
44.46%-14.29K
Cash from discontinued investing activities
Operating cash flow
44.51%-1.85M
-24.95%-3.45M
-31.68%-3.75M
44.60%-12.38M
38.50%-3.44M
21.69%-3.33M
39.77%-2.76M
64.03%-2.85M
30.80%-22.34M
4.61%-5.59M
Investing cash flow
Cash flow from continuing investing activities
0
0
88.17K
-500K
-500K
0
0
0
0
Net intangibles purchase and sale
----
----
----
---500K
----
----
----
----
--0
----
Net business purchase and sale
--0
--0
--88.17K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--88.17K
---500K
---500K
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
-71.18%1.55M
-64.75%681.42K
-4.74%3.38M
-3.26%15.23M
-21.10%4.36M
12.90%5.39M
2,431.33%1.93M
-33.91%3.55M
-64.84%15.74M
-67.64%5.52M
Net issuance payments of debt
-15.69%-177.56K
7.80%-209.21K
-1.30%-226.02K
5.89%-603.49K
--0
5.21%-153.48K
5.79%-226.91K
6.44%-223.1K
-821.86%-641.24K
--0
Net common stock issuance
--0
1,228.21%890.59K
-4.38%3.6M
-31.32%15.83M
39.53%10.3M
-75.13%1.83M
-124.88%-78.94K
-52.71%3.77M
-29.44%23.05M
19.47%7.39M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
-97.20%199K
---1
Proceeds from stock option exercised by employees
-53.32%1.73M
-100.00%36
-97.01%9
-98.64%657
-1,464,564.53%-5.95M
790,489.77%3.71M
--2.24M
-99.38%301
-99.01%48.42K
--406
Net other financing activities
----
----
----
----
----
----
----
----
---6.91M
---1.86M
Cash from discontinued financing activities
Financing cash flow
-71.18%1.55M
-64.75%681.42K
-4.74%3.38M
-3.26%15.23M
-21.10%4.36M
12.90%5.39M
2,431.33%1.93M
-33.91%3.55M
-64.84%15.74M
-67.64%5.52M
Net cash flow
Beginning cash position
-45.61%684K
65.56%3.45M
169.66%3.73M
-83.22%1.38M
97.43%3.31M
8.88%1.26M
-63.37%2.09M
-83.22%1.38M
36.07%8.25M
-76.72%1.68M
Current changes in cash
-114.38%-295.69K
-234.32%-2.77M
-139.89%-279.86K
135.56%2.35M
716.38%419.44K
297.22%2.06M
81.63%-828.38K
127.57%701.53K
-406.36%-6.6M
-107.07%-68.05K
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
-944.43%-259.71K
-397.39%-226.05K
End cash Position
-88.28%388.31K
-45.61%684K
65.56%3.45M
169.66%3.73M
169.66%3.73M
97.43%3.31M
8.88%1.26M
-63.37%2.09M
-83.22%1.38M
-83.22%1.38M
Free cash flow
44.51%-1.85M
-24.95%-3.45M
-31.68%-3.75M
42.37%-12.88M
29.56%-3.94M
21.69%-3.33M
39.77%-2.76M
64.03%-2.85M
47.56%-22.34M
65.29%-5.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.51%-1.85M-24.95%-3.45M-31.68%-3.75M44.60%-12.38M38.50%-3.44M21.69%-3.33M39.77%-2.76M64.03%-2.85M30.80%-22.34M4.61%-5.59M
Net income from continuing operations 24.84%-2.58M-110.25%-8.81M236.77%5.57M-7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M
Operating gains losses --------------------------------20.47%1.71M----
Depreciation and amortization -81.74%1.34K382.54%35.32K67.98%12.29K0.01%29.27K0.01%7.32K0.00%7.32K0.01%7.32K0.01%7.32K-94.60%29.27K-94.67%7.32K
Deferred tax --0--4.26M---14.86M----------0--0--0--------
Other non cash items -81.18%17.33K4,876.12%786.53K30,879.68%4.81M-43.40%157.02K-65.28%33.59K514.83%92.1K-32.75%15.81K-89.08%15.53K-91.99%277.43K-96.40%96.76K
Change In working capital 304.07%530.17K-86.70%147.86K-46.54%451.15K120.86%2.19M114.10%494.53K97.03%-259.8K166.72%1.11M-37.35%843.91K-161.41%-10.5M-151.86%-3.51M
-Change in receivables --0--0--0200.00%93.01K--0--0147.20%20K360.25%73.01K-116.87%-93.01K--98.97K
-Change in prepaid assets -64.82%152.48K4.95%351.18K-37.75%318.34K575.68%719.26K27.78%-560.19K19,337.85%433.46K26.96%334.6K42.55%511.39K-337.02%-151.21K12.29%-775.73K
-Change in payables and accrued expense 161.69%405.46K-121.63%-163.4K-53.73%127.36K114.31%1.45M138.31%1.08M92.38%-657.23K235.58%755.57K-74.19%275.27K-161.81%-10.15M-484.13%-2.82M
-Change in other current liabilities 22.92%-27.77K-2,675.03%-39.91K134.53%5.44K33.64%-74.05K-66.53%-23.8K-103.97%-36.04K105.25%1.55K68.55%-15.77K-258.74%-111.6K44.46%-14.29K
Cash from discontinued investing activities
Operating cash flow 44.51%-1.85M-24.95%-3.45M-31.68%-3.75M44.60%-12.38M38.50%-3.44M21.69%-3.33M39.77%-2.76M64.03%-2.85M30.80%-22.34M4.61%-5.59M
Investing cash flow
Cash flow from continuing investing activities 0088.17K-500K-500K0000
Net intangibles purchase and sale ---------------500K------------------0----
Net business purchase and sale --0--0--88.17K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0--88.17K---500K---500K--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities -71.18%1.55M-64.75%681.42K-4.74%3.38M-3.26%15.23M-21.10%4.36M12.90%5.39M2,431.33%1.93M-33.91%3.55M-64.84%15.74M-67.64%5.52M
Net issuance payments of debt -15.69%-177.56K7.80%-209.21K-1.30%-226.02K5.89%-603.49K--05.21%-153.48K5.79%-226.91K6.44%-223.1K-821.86%-641.24K--0
Net common stock issuance --01,228.21%890.59K-4.38%3.6M-31.32%15.83M39.53%10.3M-75.13%1.83M-124.88%-78.94K-52.71%3.77M-29.44%23.05M19.47%7.39M
Net preferred stock issuance --------------0-----------------97.20%199K---1
Proceeds from stock option exercised by employees -53.32%1.73M-100.00%36-97.01%9-98.64%657-1,464,564.53%-5.95M790,489.77%3.71M--2.24M-99.38%301-99.01%48.42K--406
Net other financing activities -----------------------------------6.91M---1.86M
Cash from discontinued financing activities
Financing cash flow -71.18%1.55M-64.75%681.42K-4.74%3.38M-3.26%15.23M-21.10%4.36M12.90%5.39M2,431.33%1.93M-33.91%3.55M-64.84%15.74M-67.64%5.52M
Net cash flow
Beginning cash position -45.61%684K65.56%3.45M169.66%3.73M-83.22%1.38M97.43%3.31M8.88%1.26M-63.37%2.09M-83.22%1.38M36.07%8.25M-76.72%1.68M
Current changes in cash -114.38%-295.69K-234.32%-2.77M-139.89%-279.86K135.56%2.35M716.38%419.44K297.22%2.06M81.63%-828.38K127.57%701.53K-406.36%-6.6M-107.07%-68.05K
Effect of exchange rate changes --------------0-----------------944.43%-259.71K-397.39%-226.05K
End cash Position -88.28%388.31K-45.61%684K65.56%3.45M169.66%3.73M169.66%3.73M97.43%3.31M8.88%1.26M-63.37%2.09M-83.22%1.38M-83.22%1.38M
Free cash flow 44.51%-1.85M-24.95%-3.45M-31.68%-3.75M42.37%-12.88M29.56%-3.94M21.69%-3.33M39.77%-2.76M64.03%-2.85M47.56%-22.34M65.29%-5.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List